Automated NGS Library Preparation Market (2026 - 2033)

Automated NGS Library Preparation Market Summary

The global automated NGS library preparation market size was valued at USD 777.2 million in 2025 and is projected to grow from USD 860.3 million in 2026 to USD 2,050.4 million by 2033, at a CAGR of 13.2% from 2026 to 2033. The North America held the largest share of 39.0% of the global market in 2025. Growth is driven by rising demand for genomic research, increased adoption of high-throughput sequencing, and the shift toward automated, efficient, and reproducible workflows supported by bioinformatics advancements.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

To learn more about this report, Download Free Sample Report

Automation as a Catalyst in NGS Workflow Transformation

The integration of automation in next-generation sequencing (NGS) library preparation is transforming public health and clinical diagnostics by reducing human error, improving consistency, and enabling higher throughput. These advantages are particularly valuable in time-sensitive and resource-constrained settings, which have accelerated demand for scalable sequencing infrastructure and automated workflows. Technologies such as automated liquid handlers and modular platforms streamline complex processes, including magnetic bead purification and enzymatic fragmentation, thereby supporting broader adoption of advanced molecular diagnostics. To capitalize on this trend, several key players have developed fully automated library preparation platforms, as shown in the figure below.

Commercially available, fully automated library preparation platforms

Source: Secondary Research, Primary Interview, Grand View Research

Note: The above table shows various fully automated library preparation platforms offered by key players, ranging from low-throughput systems (<96 samples) to mid- and high-throughput platforms (up to 384 samples).

As sequencing applications expand beyond research into clinical and epidemiological use, the role of automated library preparation becomes even more critical. The ability to process large sample volumes with minimal variability ensures reproducibility and data quality, which are essential for diagnostics, surveillance, and personalized medicine. Automation enhances efficiency while supporting the scalability needed for population-level genomics, reinforcing its growing value across academic, commercial, and public health laboratories.

Advancements In Automation And Robotics

The shift toward automation in NGS library preparation is fundamentally altering how laboratories manage scale, efficiency, and cost. Automated platforms now handle complex, multi-step protocols, from nucleic acid extraction to adapter ligation, with minimal manual intervention. This reduces turnaround times and operational burden, allowing labs to reassign skilled personnel to more analytical or interpretative roles. As demand for high-throughput sequencing in clinical and translational research grows, automation becomes a strategic imperative rather than a technical upgrade.

Moreover, automated systems are increasingly modular and adaptable, supporting diverse sample types and sequencing protocols. This flexibility allows institutions to future-proof their investments, align with evolving research priorities, and meet the rising expectations of data quality and reproducibility in modern genomics.

Market Concentration & Characteristics

The automated NGS library preparation industry is highly innovative, driven by advancements in robotics, microfluidics, and AI-powered automation. Companies are focusing on enhancing workflow efficiency, reducing sample preparation time, and improving sequencing accuracy. Emerging innovations include integrated platforms that minimize human intervention and optimize reagent usage. In addition, improvements in software solutions are enabling better data analysis and interpretation.

The automated NGS library preparation industry has witnessed moderate to high M&A activity with larger sequencing companies acquiring automation specialists to enhance their library preparation capabilities. Significant deals include acquisitions aimed at integrating automated liquid-handling technologies into NGS workflows. Strategic partnerships between biotech firms and sequencing providers are also accelerating, enabling seamless automation. These activities help companies expand their market presence and streamline product offerings.

To learn more about this report, Download Free Sample Report

Regulatory frameworks significantly influence product development and commercialization in the automated NGS library preparation industry. Organizations like the FDA and EMA enforce stringent guidelines to ensure accuracy, reproducibility, and compliance in clinical applications. Data security and privacy regulations also impact automated solutions, particularly in cloud-based and decentralized sequencing applications. Compliance challenges may affect time-to-market for new products.

The automated NGS library preparation industry is seeing continued product expansion, with companies launching automation platforms for high-throughput and low-input sequencing applications. New product lines are focusing on compatibility with various sequencing platforms, offering flexibility for researchers and clinicians. In addition, developments in pre-filled reagent kits and modular systems are simplifying workflows, making automation more accessible to smaller labs and research centers.

Leading companies in the automated NGS library preparation industry are expanding their presence across key regions to strengthen their global footprint. Companies such as Illumina and Thermo Fisher Scientific are investing in manufacturing and research facilities in the Asia-Pacific to meet the growing demand for sequencing automation. European expansion is driven by partnerships with clinical research organizations and government-funded genomics initiatives. In North America, companies are scaling operations through collaborations with biotech firms and research institutions, while emerging markets in Latin America and the Middle East are experiencing increased distributor agreements and local partnerships to improve market accessibility.

Type Insights

The targeted genome sequencing segment dominated the market, accounting for the largest revenue share of 45.5% in 2025, driven by its cost-effectiveness and high accuracy in analyzing specific genomic regions. It is widely used in oncology, rare disease research, and hereditary screening, where precise mutation detection is critical. Lower sequencing costs, reduced data processing needs, and advancements in hybridization-based capture and amplicon sequencing have further enhanced its adoption.

The whole-genome sequencing (WGS) segment is expected to register the highest CAGR of 14.4% during the forecast period, driven by its ability to provide comprehensive genomic insights. Increasing use in identifying complex genetic traits, declining sequencing costs, and improvements in library preparation workflows have enhanced its commercial viability. Growing focus on precision medicine and data-driven healthcare is further accelerating WGS adoption across research and clinical settings.

Product Insights

The kits & reagents segment dominated the market, accounting for a 65.5% share in 2025, driven by rising demand for high-throughput sequencing and standardized workflows. Automation has improved efficiency and reproducibility, boosting adoption across research and clinical settings. Increasing prevalence of genetic disorders and cancer, along with advancements in reagent formulations and growing NGS research projects, has supported its dominant position.

The instruments segment is expected to grow at the highest CAGR over the forecast period, fueled by increasing adoption of automation in genomics and clinical diagnostics. Technological advancements, rising data complexity, and growing investments from pharmaceutical and biotechnology companies are driving innovation. In addition, the need for faster sequencing turnaround times is supporting the adoption of advanced instruments.

Workflow Insights

The nucleic acid extraction segment dominated the market, accounting for 33.9% of revenue in 2025, driven by its critical role in providing high-quality input for downstream NGS applications. As the first step in library preparation, efficient extraction impacts data accuracy and sequencing success. Adoption of automated magnetic bead-based technologies has improved throughput, reduced contamination, and enhanced consistency, supporting growing demand in clinical and research settings.

The fragmentation segment is expected to grow at the highest CAGR of 15.2% over the forecast period, fueled by advancements in enzymatic fragmentation and increasing demand for automation-compatible workflows. Improved precision, reduced processing time, and the shift from mechanical methods have enhanced efficiency and scalability, further accelerating its uptake across the industry.

Application Insights

The drug & biomarker discovery segment dominated the automated NGS library preparation industry in 2025, accounting for 38.6% of revenue, driven by rising demand for targeted therapies and personalized treatment approaches. Automated workflows enable high-throughput analysis of genetic variations linked to drug response and disease progression, while advancements in bioinformatics support the identification of novel drug targets, strengthening segment growth.

The disease diagnostics segment is expected to witness significant growth over the forecast period, driven by the increasing prevalence of genetic disorders, infectious diseases, and cancer. Growing demand for accurate, rapid, and cost-effective genomic testing, along with the shift toward precision medicine, is accelerating the adoption of automated NGS platforms in clinical diagnostics.

End Use Insights

The pharmaceutical and biotechnology companies segment dominated the market in 2025, accounting for 43.2% of revenue, driven by the increasing use of genomic data in drug development and precision medicine. Moreover, the growing demand for targeted therapies, advancements in automation, and strategic collaborations between biotech firms have further supported segment growth.

To learn more about this report, Download Free Sample Report

The hospitals and clinics segment is projected to grow at the fastest CAGR over the forecast period, driven by the increasing integration of genomic technologies into routine clinical practice and the rising demand for precision medicine. Healthcare providers are increasingly adopting automated NGS library preparation systems to improve diagnostic accuracy, reduce turnaround times, and enhance workflow efficiency. The growing focus on early disease detection, personalized treatment strategies, and the management of complex conditions has further supported the widespread adoption of NGS technologies in clinical settings.

Regional Insights

North America dominates the automated NGS library preparation industry, with the largest revenue share of 39.0% in 2025, driven by strong adoption of advanced sequencing technologies across research and clinical applications. The presence of major industry players drives innovation, improving workflow efficiency and accuracy. Moreover, the growing investments in genomics and the rising prevalence of genetic disorders are driving demand for automated solutions.

To learn more about this report, Download Free Sample Report

U.S. Automated NGS Library Preparation Market Trends

The automated NGS library preparation market in the U.S. leads North America due to extensive research initiatives and the adoption of high-throughput sequencing in the biotechnology and pharmaceutical sectors, supported by expanding clinical applications, growing demand for faster workflows, and advancements in AI-driven automation.

Europe Automated NGS Library Preparation Market Trends

The automated NGS library preparation market in Europe experiences steady growth, driven by rising genomic research and biopharmaceutical developments. Increased focus on precision medicine boosts demand for efficient sequencing workflows. In addition, growing collaborations between academic institutions and industry players are enhancing market opportunities. Expanding clinical applications in rare disease diagnostics further accelerates market expansion.

The UK automated NGS library preparation market is witnessing growing adoption of automated NGS library preparation due to increasing focus on genomic sequencing in healthcare and research, supported by a strong biotechnology presence, expanding applications in agriculture and microbiome research, and continuous improvements in sequencing technologies.

The automated NGS library preparation market in Germany is driven by strong biomedical research and R&D investments, rising demand for precision diagnostics, and the presence of major life sciences companies, with expanding applications in pharmacogenomics and infectious disease surveillance, and the need for high-throughput solutions supporting growth.

Asia Pacific Automated NGS Library Preparation Market Trends

The automated NGS library preparation market in the Asia Pacific is expected to grow at the fastest CAGR of 15.5% over the forecast period, driven by increasing genomic research and healthcare investments. Rising cancer incidence fuels demand for advanced sequencing technologies. Moreover, the expanding biopharmaceutical industry is accelerating the adoption of automation for high-throughput analysis, while growing interest in personalized medicine is strengthening market expansion.

China automated NGS library preparation market is growing significantly due to increasing focus on precision medicine and genetic research, supported by an expanding biotech sector, rising chronic disease prevalence, and advancements in sequencing and bioinformatics technologies.

The automated NGS library preparation market in Japan is supported by advancements in genomics and personalized medicine, increasing use in rare disease diagnostics, strong technological capabilities, and growing applications in microbiome and infectious disease research.

MEA Automated NGS Library Preparation Market Trends

The automated NGS library preparation market in MEA is projected to witness growing adoption of automated NGS library preparation, driven by increasing focus on genomics in healthcare and agriculture. Expanding research collaborations are strengthening sequencing capabilities, while the rising burden of genetic disorders is boosting demand for efficient solutions.

Kuwait automated NGS library preparation market is anticipated to grow steadily due to rising interest in genomic medicine and personalized healthcare. Increasing demand for efficient sequencing solutions supports automation in library preparation. Expanding applications in cancer research and reproductive health boost market potential. Higher investments in biomedical research strengthen sequencing infrastructure.

Key Automated NGS Library Preparation Company Insights

The market is moderately consolidated, with key players including Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., and Hamilton Company. These companies maintain a strong market presence through advanced sequencing technologies, comprehensive product portfolios, and global distribution networks, supported by continuous innovation and strategic partnerships.

To learn more about this report, Download Free Sample Report

Meanwhile, companies like Bio-Rad Laboratories, Inc., and Revvity, Inc. are expanding their footprints by offering modular automation systems, liquid-handling platforms, and workflow-optimization tools. Innovators such as Oxford Nanopore Technologies and Pacific Biosciences of California, Inc. are gaining traction with next-generation long-read sequencing technologies, which require customized library preparation workflows. This competitive mix is driving innovation and reshaping how laboratories adopt and scale automated NGS solutions.

Recent Developments

• In March 2026, Takara Bio USA and Hamilton Company announced a co-development and co-marketing agreement to automate NGS library preparation workflows, integrating SMART-Seq kits with liquid handling systems to enhance throughput, reproducibility, and efficiency in high-capacity laboratory settings.

• In February 2025, seqWell announced the early access availability of its MosaiX Library Prep Kit for human population genomics applications such as WGS and whole exome sequencing. The kit featured seqWell’s TnX transposase, enabling improved activity and reduced insertion-site bias. It offered a 90-minute end-to-end workflow, producing PCR-ready libraries in just 45 minutes.

• In June 2024, SPT Labtech and Watchmaker Genomics partnered to simplify and streamline NGS library preparation by developing automated mRNA and DNA sequencing protocols.

• In September 2023, PacBio announced collaborations with automation providers Integra, Hamilton, Revvity, and Tecan, as part of the PacBio Compatible initiative. This initiative aimed to ensure the compatibility of products optimized for use in PacBio workflows, providing customers with automated protocols for whole-genome sequencing library preparation.

Global Automated NGS Library Preparation Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global automated NGS library preparation market based on product, type, workflow, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Instruments

  • Kits & Reagents

    • DNA Library Preparation Kits

    • RNA Library Preparation Kits

    • Exome/Targeted Capture Library Preparation Kits

    • Others 

• Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Targeted Genome Sequencing

  • Whole Genome Sequencing

  • Whole Exome Sequencing

  • Other Sequencing Types

• Workflow Outlook (Revenue, USD Million, 2021 - 2033)

  • Nucleic Acid Extraction

  • Fragmentation

  • Adapter Ligation

  • Purification & Quantification

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Drug & Biomarker Discovery

  • Disease Diagnostics

    • Cancer Diagnostics

    • Reproductive Health Diagnostics

    • Infectious Disease Diagnostics

    • Other Disease Diagnostic Applications

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals and Clinics

  • Academic and Research Institutions

  • Pharmaceutical and Biotechnology Companies

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait